[
  {
    "date": "2023-12-30",
    "symbol": "SWTX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39044",
    "entityregistrantname": "SPRINGWORKS THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "83-4066827",
    "entityaddressaddressline1": "100 Washington Blvd",
    "entityaddresscityortown": "Stamford",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6902,
    "cityareacode": "(203)",
    "localphonenumber": "883-9490",
    "security12btitle": "Common Stock, $0.0001 Par Value per Share",
    "tradingsymbol": "SWTX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1773427,
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Hartford, Connecticut",
    "cashandcashequivalentsatcarryingvalue": 176053000,
    "marketablesecurities": 303149000,
    "accountsreceivablenetcurrent": 5930000,
    "inventorynet": 3103000,
    "prepaidexpenseandotherassetscurrent": 12677000,
    "assetscurrent": 500912000,
    "marketablesecuritiesnoncurrent": 183386000,
    "propertyplantandequipmentnet": 17943000,
    "operatingleaserightofuseasset": 6144000,
    "equitymethodinvestments": 1955000,
    "restrictedcashnoncurrent": 613000,
    "otherassetsnoncurrent": 14835000,
    "assets": 725788000,
    "accountspayablecurrent": 7396000,
    "accruedliabilitiescurrent": 65569000,
    "operatingleaseliabilitycurrent": 1061000,
    "contractwithcustomerliabilitycurrent": 4144000,
    "liabilitiescurrent": 78170000,
    "operatingleaseliabilitynoncurrent": 5996000,
    "contractwithcustomerliabilitynoncurrent": 15403000,
    "liabilities": 99569000,
    "commonstockvalue": 7000,
    "additionalpaidincapital": 1524196000,
    "retainedearningsaccumulateddeficit": -895034000,
    "treasurystockcommonvalue": 4141000,
    "accumulatedothercomprehensiveincomelossnetoftax": 1191000,
    "stockholdersequity": 626219000,
    "liabilitiesandstockholdersequity": 725788000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 73620361,
    "commonstocksharesoutstanding": 73486699,
    "treasurystockcommonshares": 133662,
    "revenuefromcontractwithcustomerincludingassessedtax": 5447000,
    "costofgoodsandservicessold": 422000,
    "researchanddevelopmentexpense": 150487000,
    "sellinggeneralandadministrativeexpense": 197551000,
    "costsandexpenses": 348460000,
    "operatingincomeloss": -343013000,
    "interestandotherincome": 22947000,
    "nonoperatingincomeexpense": 22947000,
    "incomelossfromequitymethodinvestments": -5038000,
    "netincomeloss": -325104000,
    "earningspersharebasic": -5.15,
    "earningspersharediluted": -5.15,
    "weightedaveragenumberofsharesoutstandingbasic": 63123936,
    "weightedaveragenumberofdilutedsharesoutstanding": 63123936,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2023#ProductMember",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 1958000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 1958000,
    "comprehensiveincomenetoftax": -323146000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 94534000,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 10905171,
    "stockissuedduringperiodsharesrestrictedstockawardforfeited": 21113,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 238725,
    "stockissuedduringperiodvaluestockoptionsexercised": 139000,
    "stockissuedduringperiodsharesstockoptionsexercised": 44250,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 2800000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 103463,
    "depreciationdepletionandamortization": 1667000,
    "noncashoperatingleaseexpense": 1653000,
    "sharebasedcompensation": 94534000,
    "increasedecreaseinaccountsreceivable": 5930000,
    "increasedecreaseininventories": 3103000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5129000,
    "increasedecreaseinothercurrentassets": 838000,
    "increasedecreaseinaccountspayable": -196000,
    "increasedecreaseinaccruedliabilities": 15906000,
    "increasedecreaseinleaseliability": -1293000,
    "netcashprovidedbyusedinoperatingactivities": -222795000,
    "paymentstoacquirepropertyplantandequipment": 7385000,
    "paymentstoacquireequitymethodinvestments": 2800000,
    "paymentstoacquiremarketablesecurities": 575724000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 620663000,
    "netcashprovidedbyusedininvestingactivities": 34754000,
    "proceedsfromissuanceofcommonstock": 299300000,
    "paymentsforrepurchaseofcommonstock": 2800000,
    "proceedsfromstockoptionsexercised": 139000,
    "netcashprovidedbyusedinfinancingactivities": 296639000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 108598000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 176666000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2637000,
    "milestonepaymentforfirstcommercialsaleincludedinaccruedexpenses": 11250000,
    "licenseandcollaborationagreementstextblock": "License and Collaboration Agreements",
    "leasebalancesheetdisclosuretabletextblock": "The Company’s leases are included on its consolidated balance sheets as follows:(in thousands)As of December 31, 2023As of December 31, 2022Operating leasesOperating lease right-of-use-assets$6,144 $4,698 Total operating lease assets$6,144 $4,698 Operating lease liabilities, current$1,061 $483 Operating lease liabilities, long-term5,996 4,768 Total operating lease liabilities$7,057 $5,251",
    "workingcapital": 422700000,
    "cashcashequivalentsandshortterminvestments": 662600000,
    "numberofoperatingsegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "availableforsaledebtsecuritiesamortizedcostbasis": 228579000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 212000,
    "availableforsalesecuritiesdebtsecurities": 228791000,
    "cashandcashequivalentsfairvaluedisclosure": 14434000,
    "investmentsfairvaluedisclosure": 228791000,
    "longterminvestmentsfairvaluedisclosure": 141857000,
    "assetsfairvaluedisclosure": 550600000,
    "propertyplantandequipmentgross": 826000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2658000,
    "propertyplantandequipmentusefullife": "P5Y",
    "depreciation": 1600000,
    "finitelivedintangibleassetsgross": 11250000,
    "finitelivedintangibleassetsaccumulatedamortization": 50000,
    "finitelivedintangibleassetsnet": 11200000,
    "finitelivedintangibleassetusefullife": "P19Y4M24D",
    "amortizationofintangibleassets": 100000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 600000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 600000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 600000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 600000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 600000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 8200000,
    "operatingleasecost": 1653000,
    "variableleasecost": 866000,
    "leasecost": 2519000,
    "operatingleaseliability": 7057000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1476000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1999000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2002000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1904000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 646000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8027000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 970000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.058,
    "operatingleasepayments": 1293000,
    "employeerelatedliabilitiescurrent": 26047000,
    "accruedresearchanddevelopmentexpenses": 15129000,
    "accruedmilestonecurrent": 11250000,
    "otheraccruedliabilitiescurrent": 13143000,
    "allocatedsharebasedcompensationexpense": 34398000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2543163,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0346,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0473,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.767,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 117700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11588576,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2994704,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 538693,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 6711390,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 35.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 27.65,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 44.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 32.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 117631827,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 88814151,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 106834,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1163390,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 93812,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 21113,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 70.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 27.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 71.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 63.38,
    "milestonepaymentsoutstanding": 11300000,
    "collaborativearrangementmaximumproceedsfromachievementofcommercialmilestone": 550000000,
    "equitymethodinvestmentownershippercentage": 0.389,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 472100000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 365500000,
    "operatinglosscarryforwards": 467800000,
    "percentageoftaxableincomeavailabletooffset": 0.8,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 4300000,
    "taxcreditcarryforwardamount": 33500000,
    "valuationallowancedeferredtaxassetchangeinamount": 69400000,
    "deferredtaxassetsoperatinglosscarryforwards": 121029000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6069000,
    "deferredtaxassetstaxcreditorphandrug": 27515000,
    "deferredtaxassetcapitalizedresearchanddevelopment": 41588000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 26429000,
    "deferredtaxassetsdeferredincome": 4105000,
    "deferredtaxassetsother": 3031000,
    "deferredtaxassetsgross": 229766000,
    "deferredtaxliabilitiesleasingarrangements": 1290000,
    "deferredtaxliabilitiespropertyplantandequipment": 1255000,
    "deferredtaxliabilitiesother": 2000,
    "deferredtaxassetsvaluationallowance": 227219000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0217,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.0121,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0081,
    "effectiveincometaxratereconciliationdeductionsmedicareprescriptiondrugbenefit": 0.025,
    "effectiveincometaxratereconciliationsection162mlimitationpercent": -0.0339,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.0054,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2134,
    "employeebenefitsandsharebasedcompensation": 1300000,
    "netincomelossavailabletocommonstockholdersbasic": -325104000,
    "netincomelossavailabletocommonstockholdersdiluted": -325104000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11588576
  },
  {
    "date": "2022-12-30",
    "symbol": "SWTX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2022-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39044",
    "entityregistrantname": "SPRINGWORKS THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "83-4066827",
    "entityaddressaddressline1": "100 Washington Blvd",
    "entityaddresscityortown": "Stamford",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6902,
    "cityareacode": "(203)",
    "localphonenumber": "883-9490",
    "security12btitle": "Common Stock, $0.0001 Par Value per Share",
    "tradingsymbol": "SWTX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1773427,
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "New York, New York",
    "cashandcashequivalentsatcarryingvalue": 67490000,
    "marketablesecuritiescurrent": 524722000,
    "prepaidexpenseandotherassets": 7548000,
    "assetscurrent": 599760000,
    "marketablesecuritiesnoncurrent": 4794000,
    "propertyplantandequipmentnet": 13571000,
    "operatingleaserightofuseasset": 4698000,
    "equitymethodinvestments": 4193000,
    "restrictedcashnoncurrent": 578000,
    "otherassetsnoncurrent": 2648000,
    "assets": 630242000,
    "accountspayablecurrent": 8010000,
    "accruedliabilitiescurrent": 39242000,
    "operatingleaseliabilitycurrent": 483000,
    "contractwithcustomerliabilitycurrent": 3314000,
    "liabilitiescurrent": 51049000,
    "operatingleaseliabilitynoncurrent": 4768000,
    "contractwithcustomerliabilitynoncurrent": 16233000,
    "liabilities": 72050000,
    "commonstockvalue": 6000,
    "additionalpaidincapital": 1130224000,
    "retainedearningsaccumulateddeficit": -569930000,
    "treasurystockcommonvalue": 1341000,
    "accumulatedothercomprehensiveincomelossnetoftax": -767000,
    "stockholdersequity": 558192000,
    "liabilitiesandstockholdersequity": 630242000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 62453328,
    "commonstocksharesoutstanding": 62423129,
    "treasurystockcommonshares": 30199,
    "researchanddevelopmentexpense": 146122000,
    "generalandadministrativeexpense": 134552000,
    "operatingexpenses": 280674000,
    "operatingincomeloss": -280674000,
    "othernonoperatingincomeexpense": -138000,
    "interestincomeexpensenet": 6285000,
    "nonoperatingincomeexpense": 6147000,
    "incomelossfromequitymethodinvestments": -2890000,
    "netincomeloss": -277417000,
    "earningspersharebasic": -5.21,
    "earningspersharediluted": -5.21,
    "weightedaveragenumberofsharesoutstandingbasic": 53290528,
    "weightedaveragenumberofdilutedsharesoutstanding": 53290528,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseAndServiceMember",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -455000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -455000,
    "comprehensiveincomenetoftax": -277872000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 72965000,
    "stockissuedduringperiodvaluenewissues": 55454000,
    "stockissuedduringperiodsharesnewissues": 2050819,
    "stockissuedduringperiodsharesrestrictedstockawardforfeited": 27957,
    "stockissuedduringperiodvaluestockoptionsexercised": 1977000,
    "stockissuedduringperiodsharesstockoptionsexercised": 223467,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 1341000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 30199,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 36625,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 24369,
    "depreciation": 765000,
    "noncashoperatingleaseexpense": 1131000,
    "sharebasedcompensation": 72965000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1861000,
    "increasedecreaseinothercurrentassets": -61000,
    "increasedecreaseinaccountspayable": 4168000,
    "increasedecreaseinaccruedliabilities": 13325000,
    "increasedecreaseinleaseliability": -859000,
    "increasedecreaseincontractwithcustomerliability": 19547000,
    "netcashprovidedbyusedinoperatingactivities": -161563000,
    "paymentstoacquirepropertyplantandequipment": 10196000,
    "paymentstoacquireequitymethodinvestments": 4200000,
    "paymentstoacquiremarketablesecurities": 481050000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 279849000,
    "netcashprovidedbyusedininvestingactivities": -215597000,
    "proceedsfromissuanceofprivateplacement": 55454000,
    "paymentsforrepurchaseofcommonstock": 1341000,
    "proceedsfromstockoptionsexercised": 1977000,
    "netcashprovidedbyusedinfinancingactivities": 340702000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -36458000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 68068000,
    "operatingleaseliability": 5251000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 5580000,
    "numberofclinicaltrials": 2,
    "saleofstocknumberofsharesissuedintransaction": 2247500,
    "saleofstockconsiderationreceivedontransactiongrossproceeds": 69700000,
    "saleofstockconsiderationreceivedontransaction": 67800000,
    "saleofstockcommissionfee": 1900000,
    "saleofstocksharesremaininginofferingvalue": 130300000,
    "workingcapital": 548700000,
    "cashcashequivalentsandshortterminvestments": 597000000,
    "numberofoperatingsegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "availableforsaledebtsecuritiesamortizedcostbasis": 232229000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 690000,
    "availableforsalesecuritiesdebtsecurities": 231539000,
    "cashandcashequivalentsfairvaluedisclosure": 22494000,
    "investmentsfairvaluedisclosure": 231539000,
    "assetsfairvaluedisclosure": 552010000,
    "propertyplantandequipmentgross": 826000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1245000,
    "propertyplantandequipmentusefullife": "P5Y",
    "operatingleasecost": 1131000,
    "variableleasecost": 336000,
    "leasecost": 1467000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 783000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1155000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1184000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1213000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1244000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearthree": 424000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6003000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 752000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.042,
    "operatingleasepayments": 859000,
    "accruedprofessionalfeescurrent": 1780000,
    "employeerelatedliabilitiescurrent": 19142000,
    "accruedresearchanddevelopmentexpenses": 12321000,
    "otheraccruedliabilitiescurrent": 5999000,
    "allocatedsharebasedcompensationexpense": 29373000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 3162205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0423,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9176815,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3207347,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 520478,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 4392905,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 38.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 43.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.84,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 68.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 28.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 53719297,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 48765645,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 137400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 221759,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 36625,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 257219,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 27957,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 70.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 61.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 32.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 79.25,
    "equitymethodinvestmentownershippercentage": 0.389,
    "equitymethodinvestmentspurchaseobligationvalue": 2800000,
    "equitymethodinvestmentmaximumriskexposure": 7000000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 368300000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 260900000,
    "operatinglosscarryforwards": 364000000,
    "percentageoftaxableincomeavailabletooffset": 0.8,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 4300000,
    "taxcreditcarryforwardamount": 22700000,
    "valuationallowancedeferredtaxassetchangeinamount": 68600000,
    "deferredtaxassetsoperatinglosscarryforwards": 93032000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3422000,
    "deferredtaxassetstaxcreditorphandrug": 19401000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 136000,
    "deferredtaxassetcapitalizedresearchanddevelopment": 21262000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 20286000,
    "deferredtaxassetsoperatingleases": 1103000,
    "deferredtaxassetsequitymethodinvestments": 286000,
    "deferredtaxassetsgross": 158928000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 987000,
    "deferredtaxliabilitiespropertyplantandequipment": 113000,
    "deferredtaxliabilitiesother": 2000,
    "deferredtaxassetsvaluationallowance": 157826000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0233,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.0077,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.0027,
    "effectiveincometaxratereconciliationdeductionsmedicareprescriptiondrugbenefit": -0.0187,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.247,
    "employeebenefitsandsharebasedcompensation": 1000000,
    "netincomelossavailabletocommonstockholdersbasic": -277417000,
    "netincomelossavailabletocommonstockholdersdiluted": -277417000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9176815
  },
  {
    "date": "2021-12-30",
    "symbol": "SWTX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "December 31",
    "documentperiodenddate": "December 31, 2021",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39044",
    "entityregistrantname": "SPRINGWORKS THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "83-4066827",
    "entityaddressaddressline1": "100 Washington Blvd",
    "entityaddresscityortown": "Stamford",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6902,
    "cityareacode": "(203)",
    "localphonenumber": "883-9490",
    "security12btitle": "Common Stock, $0.0001 Par Value per Share",
    "tradingsymbol": "SWTX",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "x",
    "entitycentralindexkey": 1773427,
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "New York, New York",
    "cashandcashequivalentsatcarryingvalue": 103961000,
    "marketablesecuritiescurrent": 269540000,
    "prepaidexpenseandotherassets": 9409000,
    "assetscurrent": 382910000,
    "marketablesecuritiesnoncurrent": 59230000,
    "propertyplantandequipmentnet": 3187000,
    "operatingleaserightofuseasset": 1010000,
    "equitymethodinvestments": 2900000,
    "restrictedcashnoncurrent": 565000,
    "otherassetsnoncurrent": 2709000,
    "assets": 452494000,
    "accountspayablecurrent": 3429000,
    "accruedliabilitiescurrent": 25378000,
    "operatingleaseliabilitycurrent": 1162000,
    "liabilitiescurrent": 29969000,
    "operatingleaseliabilitynoncurrent": 129000,
    "liabilities": 30098000,
    "commonstockvalue": 5000,
    "additionalpaidincapital": 715216000,
    "accumulatedothercomprehensiveincomelossnetoftax": -312000,
    "retainedearningsaccumulateddeficit": -292513000,
    "stockholdersequity": -292513000,
    "liabilitiesandstockholdersequity": 452494000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 49247985,
    "commonstocksharesoutstanding": 49247985,
    "researchanddevelopmentexpense": 1100000,
    "generalandadministrativeexpense": 71792000,
    "operatingexpenses": 173468000,
    "operatingincomeloss": -173468000,
    "othernonoperatingincomeexpense": -152000,
    "investmentincomenet": 698000,
    "nonoperatingincomeexpense": 546000,
    "incomelossfromequitymethodinvestments": -1000000,
    "netincomeloss": -173910000,
    "netincomelossavailabletocommonstockholdersbasic": -173910000,
    "netincomelossavailabletocommonstockholdersdiluted": -173910000,
    "incomelossfromcontinuingoperationsperbasicshare": -3.59,
    "incomelossfromcontinuingoperationsperdilutedshare": -3.59,
    "weightedaveragenumberofsharesoutstandingbasic": 48497790,
    "weightedaveragenumberofdilutedsharesoutstanding": 48497790,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -353000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -353000,
    "comprehensiveincomelossnetoftaxattributabletoparentbeforetheextinguishmentofpreferredunits": -174263000,
    "comprehensiveincomenetoftax": -174263000,
    "sharesoutstanding": 49247985,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 38444000,
    "stockissuedduringperiodsharesrestrictedstockawardforfeited": 55475,
    "stockissuedduringperiodvaluestockoptionsexercised": 1157000,
    "stockissuedduringperiodsharesstockoptionsexercised": 151643,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 332226,
    "othercomprehensiveincomelossnetoftax": -353000,
    "depreciation": 490000,
    "noncashoperatingleaseexpense": 993000,
    "sharebasedcompensation": 38444000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 4609000,
    "increasedecreaseinothercurrentassets": 707000,
    "increasedecreaseinaccountspayable": 2074000,
    "increasedecreaseinaccruedliabilities": 9912000,
    "increasedecreaseinleaseliability": -1388000,
    "increasedecreaseinothernoncurrentliabilities": -164000,
    "netcashprovidedbyusedinoperatingactivities": -127877000,
    "paymentstoacquirepropertyplantandequipment": 2016000,
    "paymentstoacquiremarketablesecurities": 305423000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 391031000,
    "netcashprovidedbyusedininvestingactivities": 83592000,
    "proceedsfromstockoptionsexercised": 1157000,
    "netcashprovidedbyusedinfinancingactivities": 1157000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -43128000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 104526000,
    "operatingleaseliability": 1291000,
    "numberofclinicaltrials": 2,
    "workingcapital": 352900000,
    "cashcashequivalentsandshortterminvestments": 432700000,
    "numberofoperatingsegments": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "minorityinterestownershippercentagebyparent": 1,
    "availableforsaledebtsecuritiesamortizedcostbasis": 329082000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 315000,
    "availableforsalesecuritiesdebtsecurities": 328770000,
    "cashandcashequivalentsfairvaluedisclosure": 89905000,
    "investmentsfairvaluedisclosure": 85896000,
    "longterminvestmentsfairvaluedisclosure": 59230000,
    "assetsfairvaluedisclosure": 164573000,
    "propertyplantandequipmentgross": 4206000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1019000,
    "propertyplantandequipmentusefullife": 3,
    "operatingleasecost": 993000,
    "variableleasecost": 548000,
    "leasecost": 1541000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1182000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 135000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1317000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 26000,
    "operatingleaseweightedaverageremainingleaseterm1": 1.1,
    "operatingleaseweightedaveragediscountratepercent": 0.035,
    "operatingleasepayments": 1388000,
    "accruedprofessionalfeescurrent": 1108000,
    "employeerelatedliabilitiescurrent": 12081000,
    "accruedresearchanddevelopmentexpenses": 10069000,
    "otheraccruedliabilitiescurrent": 2120000,
    "allocatedsharebasedcompensationexpense": 5400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1360410,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013300000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6713413,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2547813,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 188303,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 44103,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 37.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 73.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 37.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 17.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 7.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 196012147,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 122887280,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 18500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 470310,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 332226,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 493309,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 55475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 50.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 73.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 13.75,
    "equitymethodinvestmentownershippercentage": 0.389,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 257800000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 3700000,
    "operatinglosscarryforwards": 253500000,
    "percentageoftaxableincomeavailabletooffset": 0.8,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 4300000,
    "taxcreditcarryforwardamount": 16700000,
    "valuationallowancedeferredtaxassetchangeinamount": 55000000,
    "deferredtaxassetsoperatinglosscarryforwards": 63418000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2581000,
    "deferredtaxassetstaxcreditorphandrug": 14198000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 18000,
    "deferredtaxassetspropertyplantandequipment": 128000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8476000,
    "deferredtaxassetsoperatingleases": 271000,
    "deferredtaxassetsequitymethodinvestments": 356000,
    "deferredtaxassetsgross": 89446000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 212000,
    "deferredtaxliabilitiesother": 2000,
    "deferredtaxassetsvaluationallowance": 89232000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationfederalandstatereturntoprovisionadjustments": 0.051500000000000004,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.0003,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.005,
    "effectiveincometaxratereconciliationdeductionsmedicareprescriptiondrugbenefit": 0.0499,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3161,
    "employeebenefitsandsharebasedcompensation": 500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7183723
  }
]